Virtus ETF Advisers’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $220K | Sell |
625
-150
| -19% | -$53.5K | 0.1% | 219 |
|
|
2025
Q4 | $254K | Buy |
775
+234
| +43% | +$74.2K | 0.12% | 192 |
|
|
2025
Q3 | $153K | Buy |
+541
| New | +$157K | 0.08% | 248 |
|
|
2025
Q1 | – | Sell |
-1,276
| Closed | -$333K | – | 435 |
|
|
2024
Q4 | $333K | Buy |
1,276
+173
| +16% | +$51.3K | 0.14% | 226 |
|
|
2024
Q3 | $355K | Hold |
1,103
| – | – | 0.17% | 213 |
|
|
2024
Q2 | $345K | Sell |
1,103
-278
| -20% | -$81.7K | 0.17% | 201 |
|
|
2024
Q1 | $393K | Buy |
1,381
+200
| +17% | +$58.5K | 0.21% | 196 |
|
|
2023
Q4 | $340K | Sell |
1,181
-198
| -14% | -$53.9K | 0.22% | 195 |
|
|
2023
Q3 | $371K | Sell |
1,379
-167
| -11% | -$41.7K | 0.23% | 184 |
|
|
2023
Q2 | $343K | Buy |
1,546
+398
| +35% | +$92.4K | 0.2% | 161 |
|
|
2023
Q1 | $278K | Buy |
1,148
+32
| +3% | +$7.86K | 0.15% | 258 |
|
|
2022
Q4 | $293K | Buy |
1,116
+115
| +11% | +$30.8K | 0.15% | 277 |
|
|
2022
Q3 | $226K | Buy |
1,001
+16
| +2% | +$3.88K | 0.09% | 306 |
|
|
2022
Q2 | $240K | Sell |
985
-755
| -43% | -$185K | 0.09% | 306 |
|
|
2022
Q1 | $421K | Hold |
1,740
| – | – | 0.19% | 151 |
|
|
2021
Q4 | $391K | Sell |
1,740
-151
| -8% | -$31.9K | 0.15% | 157 |
|
|
2021
Q3 | $402K | Sell |
1,891
-179
| -9% | -$41.2K | 0.18% | 174 |
|
|
2021
Q2 | $505K | Sell |
2,070
-680
| -25% | -$167K | 0.21% | 145 |
|
|
2021
Q1 | $684K | Buy |
2,750
+98
| +4% | +$23.4K | 0.29% | 109 |
|
|
2020
Q4 | $610K | Sell |
2,652
-31
| -1% | -$7.15K | 0.25% | 107 |
|
|
2020
Q3 | $682K | Buy |
2,683
+227
| +9% | +$56.2K | 0.36% | 109 |
|
|
2020
Q2 | $579K | Sell |
2,456
-33
| -1% | -$7.53K | 0.27% | 124 |
|
|
2020
Q1 | $505K | Sell |
2,489
-210
| -8% | -$45.9K | 0.21% | 170 |
|
|
2019
Q4 | $651K | Sell |
2,699
-1,240
| -31% | -$273K | 0.11% | 169 |
|
|
2019
Q3 | $762K | Sell |
3,939
-658
| -14% | -$126K | 0.15% | 156 |
|
|
2019
Q2 | $847K | Buy |
+4,597
| New | +$823K | 0.18% | 170 |
|
|
2016
Q4 | – | Sell |
-4,071
| Closed | -$679K | – | 179 |
|
|
2016
Q3 | $679K | Buy |
4,071
+514
| +14% | +$86.9K | 0.33% | 54 |
|
|
2016
Q2 | $541K | Sell |
3,557
-87
| -2% | -$13.5K | 0.4% | 43 |
|
|
2016
Q1 | $546K | Hold |
3,644
| – | – | 0.75% | 31 |
|
|
2015
Q4 | $592K | Buy |
+3,644
| New | +$573K | 1.62% | 20 |
|
Other funds holding AMGN
VCM
VPM
Virtus ETF Advisers's AMGN Position: Q1 2026 in Review
Virtus ETF Advisers reduced its Amgen (AMGN) stake by 19% in Q1 2026, selling an estimated $53.5K and leaving 625 shares worth $220K. The position accounts for 0.1% of the portfolio, ranked #219.
Virtus ETF Advisers first reported a position in AMGN in Q4 2015 and has held it in 30 quarters since. The position peaked at $847K in Q2 2019. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Virtus ETF Advisers held 625 shares of Amgen worth $220K as of Q1 2026.
- Virtus ETF Advisers sold 150 Amgen shares in Q1 2026, an estimated $53.5K.
- Amgen made up 0.1% of Virtus ETF Advisers's portfolio in Q1 2026, its #219 holding.
- Virtus ETF Advisers first reported a position in Amgen in Q4 2015 and has held it in 30 quarters since.
- Virtus ETF Advisers's Amgen position peaked at $847K in Q2 2019.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Virtus ETF Advisers's 13F filing for Q1 2026, filed 14 May 2026.